{
    "Trade/Device Name(s)": [
        "GlucoDr\u2122 Plus System",
        "GlucoDr\u2122M Plus system",
        "GlucoDr\u2122 Plus Test Meter",
        "GlucoDr\u2122 Plus Test strips",
        "GlucoDr\u2122 Plus control solution"
    ],
    "Submitter Information": "All Medicus Co., Ltd.",
    "510(k) Number": "K082328",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043474"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "January 16, 2009",
    "Summary Letter Received Date": "January 16, 2009",
    "Submission Date": "May, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoDr\u2122 Plus Test Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Measurement of electrical current from glucose reaction"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test strips",
        "Control solution"
    ],
    "Document Summary": "FDA 510(k) summary for GlucoDr\u2122 Plus blood glucose monitoring system for quantitative glucose measurement in whole blood using electrochemical detection",
    "Indications for Use Summary": "For in vitro quantitative measurement of glucose in venous and capillary whole blood from traditional and alternative sites by healthcare professionals or self-testing diabetic lay users to aid monitoring diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}